GIPR antagonist 4

GIPR antagonist 4 is an orally active GIPR antagonist with an IC50 of 4.1 nM. GIPR antagonist 4 exerts its antagonistic effect by competitively binding to GIPR and blocking the increase in Gαs-mediated cAMP production induced by GIP agonists. The combination of GIPR antagonist 4 and Liraglutide (HY-P0014) can enhance the weight loss effect of the single drug. GIPR antagonist 4 can be used for research related to obesity and metabolic diseases.

Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.

  • CAS No.: 3059496-70-4
  • Formule: C28H29N3O4
  • Masse moléculaire:471.55
  • Stockage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Activité biologique
  • Chemical Information
  • Pureté et documentation
  • Références
  • Help & FAQs
MOQ
Minimum order quantity
100 mg

Obtenir un devis En stock

Other size
Obtenir un devis
Please select quantity
Amount: USD 0.00